LoF variants in SCN2A have also been identified in patients with later onset epilepsy and in patients with intellectual disability, ASD and schizophrenia without seizures (Carroll et al., 2016; Codina‐Solà et al., 2015; Wolff et al., 2017). This evidence concerns the gene SCN2A and epilepsy.